The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Kalpit Patel is an analyst at B. Riley Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | VRDN | Buy Now | Viridian Therapeutics | $14.33 | 39.57% | $25 → $20 | Downgrade | Buy → Neutral | Get Alert |
| 04/30/2024 | OVID | Buy Now | Ovid Therapeutics | $3.15 | 185.71% | → $9 | Initiates | → Buy | Get Alert |
| 03/28/2024 | PDSB | Buy Now | PDS Biotechnology | $3.46 | 217.92% | $14 → $11 | Reiterates | Buy → Buy | Get Alert |
| 03/21/2024 | VRDN | Buy Now | Viridian Therapeutics | $14.33 | 74.46% | $29 → $25 | Maintains | Buy | Get Alert |
| 03/06/2024 | RIGL | Buy Now | Rigel Pharmaceuticals | $0.95 | 31.27% | $1.25 → $1.25 | Maintains | Neutral | Get Alert |
| 12/12/2023 | XFOR | Buy Now | X4 Pharmaceuticals | $0.92 | 8.77% | $3 → $1 | Downgrade | Buy → Neutral | Get Alert |
| 10/09/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $65 → $60 | Downgrade | Buy → Neutral | Get Alert |
| 09/29/2023 | VSTM | Buy Now | Verastem | $12.00 | 75% | $21 → $21 | Reiterates | Buy → Buy | Get Alert |
| 09/27/2023 | VSTM | Buy Now | Verastem | $12.00 | 75% | → $21 | Initiates | → Buy | Get Alert |
| 09/12/2023 | BCYC | Buy Now | Bicycle Therapeutics | $21.48 | 53.67% | → $33 | Upgrade | Neutral → Buy | Get Alert |
| 09/11/2023 | BCYC | Buy Now | Bicycle Therapeutics | $21.48 | 53.67% | $33 → $33 | Upgrade | Neutral → Buy | Get Alert |
| 09/07/2023 | DERM | Buy Now | Journey Medical | $3.53 | 69.97% | → $6 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $45 | Upgrade | Neutral → Buy | Get Alert |
| 07/25/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.45 | 76.04% | $34 → $36 | Maintains | Buy | Get Alert |
| 07/24/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $51 → $45 | Maintains | Neutral | Get Alert |
| 07/12/2023 | DERM | Buy Now | Journey Medical | $3.53 | 69.97% | $3 → $6 | Maintains | Buy | Get Alert |
| 05/23/2023 | DERM | Buy Now | Journey Medical | $3.53 | -15.01% | $6 → $3 | Maintains | Buy | Get Alert |
| 04/27/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | $20.71 | -37.23% | → $13 | Initiates | → Buy | Get Alert |
| 03/30/2023 | DERM | Buy Now | Journey Medical | $3.53 | 69.97% | → $6 | Reiterates | → Buy | Get Alert |
| 03/29/2023 | PDSB | Buy Now | PDS Biotechnology | $3.46 | 246.82% | → $12 | Reiterates | → Buy | Get Alert |
| 03/20/2023 | GERN | Buy Now | Geron | $3.91 | 27.88% | → $5 | Reiterates | → Buy | Get Alert |
| 01/23/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $52 → $56 | Maintains | Neutral | Get Alert |
| 11/16/2022 | INFI | Buy Now | Infinity Pharmaceuticals | $0.02 | 9275% | $3 → $1.5 | Downgrade | Buy → Neutral | Get Alert |
| 11/11/2022 | INAB | Buy Now | IN8bio | $1.05 | 185.88% | $9 → $3 | Downgrade | Buy → Neutral | Get Alert |
| 11/01/2022 | PDSB | Buy Now | PDS Biotechnology | $3.46 | 189.02% | → $10 | Initiates | → Buy | Get Alert |
| 10/28/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $72 | Initiates | → Neutral | Get Alert |
| 09/22/2022 | ALLO | Buy Now | Allogene Therapeutics | $2.80 | 543.43% | $21 → $18 | Maintains | Buy | Get Alert |
| 07/28/2022 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.45 | 51.59% | → $31 | Reinstates | → Buy | Get Alert |
| 07/28/2022 | GERN | Buy Now | Geron | $3.91 | 2.3% | → $4 | Reinstates | → Buy | Get Alert |
| 07/19/2022 | ENTX | Buy Now | Entera Bio | $2.38 | 109.64% | $6 → $5 | Maintains | Buy | Get Alert |
